IMU 4.26% 4.5¢ imugene limited

Leslie Chong Interview 3, page-24

  1. 9,595 Posts.
    lightbulb Created with Sketch. 330
    Yes, Viralytics got taken out for $500m.

    There's the PH connection, but also they were in the cancer immunology field.

    Their drug helped two T cell therapy drugs, where as imu's technology appears to supersede T therapy drugs.

    Viralytics was only really tempting for Merck or Bristol Myers. Imugene should be tempting to all pharmas. Not just because of the lead it will give them, but it's equally important that the competition doesn't get it - hence a bidding war could ensue.

    I think those who make the first bid or deal has to make it big enough to stick.

    cheers
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
4.5¢
Change
-0.002(4.26%)
Mkt cap ! $386.7M
Open High Low Value Volume
4.7¢ 4.8¢ 4.4¢ $890.8K 19.42M

Buyers (Bids)

No. Vol. Price($)
2 176601 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 969572 8
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.